News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Meet the most innovative and inventive pharmaceutical companies of 2021
Three life science companies with ties to Seattle were named to Fortune’s list of the 2021 most innovative and inventive pharmaceutical companies, which highlights companies
Oxford continues life sciences expansion with $119M Seattle buy
A Seattle office building was acquired by Toronto-based Oxford Properties Group, which intends to convert it into a fully dedicated life science facility. The purchase
Bothell’s biotech real estate market stays hot with $53M campus sale
Partners Rialto Capital of Miami and SteelWave LLC have bought Bothell-based Highlands Campus Tech Centre, home to Seagen, a leading biotech company that reported a
UW spinout Icosavax raises $100M for vaccine development
Icosavax Inc., a biotech company focused on vaccine development, announced a $100M Series B investment round. Icosavax, a spinout from the University of Washington plans
Seattle biotech firm Impel NeuroPharma files for $75M IPO
Impel NeuroPharma (Impel), a Seattle-based biotech company led by Adrian Adams, has indicated the company plans to go public. According to GeekWire, Impel filed paperwork
Seattle biotech startup Outpace Bio raises $30M to fight cancer with custom-designed proteins
Outpace Bio, a biotech company based in Seattle, announced it has raised $30M in a Series A round, led by ARTIS Ventures and Lyell. Outpace,